BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28143538)

  • 1. Prevalence of undiagnosed type 2 diabetes in patients admitted with acute coronary syndrome: the utility of easily reproducible screening methods.
    Karamat MA; Raja UY; Manley SE; Jones A; Hanif W; Tahrani AA
    BMC Endocr Disord; 2017 Jan; 17(1):3. PubMed ID: 28143538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology.
    Shahim B; Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
    Cardiovasc Diabetol; 2018 Jan; 17(1):21. PubMed ID: 29368616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes.
    Hage C; Lundman P; Rydén L; Mellbin L
    Eur J Prev Cardiol; 2013 Aug; 20(4):549-54. PubMed ID: 22456695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method.
    Lerchbaum E; Schwetz V; Giuliani A; Obermayer-Pietsch B
    Hum Reprod; 2013 Sep; 28(9):2537-44. PubMed ID: 23756702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for type 2 diabetes with random finger-prick glucose and bedside HbA1c in an Australian emergency department.
    Jelinek GA; Weiland TJ; Moore G; Tan G; Maslin M; Bowman K; Ward G; O'Dea K
    Emerg Med Australas; 2010 Oct; 22(5):427-34. PubMed ID: 21040483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycated haemoglobin threshold for dysglycaemia screening, and application to metabolic syndrome diagnosis in HIV-infected Africans.
    Nguyen KA; Peer N; de Villiers A; Mukasa B; Matsha TE; Mills EJ; Kengne AP
    PLoS One; 2019; 14(1):e0211483. PubMed ID: 30703147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editor's Choice- Diagnosis of type 2 diabetes and prediabetes among patients with acute coronary syndromes.
    Bjarnason TA; Kristinsdottir LB; Oskarsdottir ES; Hafthorsson SO; Olafsson I; Lund SH; Andersen K
    Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):744-749. PubMed ID: 27625341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of HbA1c versus oral glucose tolerance test (OGTT) as a screening tool to diagnose dysglycemic status in high-risk Thai patients.
    Thewjitcharoen Y; Jones Elizabeth A; Butadej S; Nakasatien S; Chotwanvirat P; Wanothayaroj E; Krittiyawong S; Himathongkam T; Himathongkam T
    BMC Endocr Disord; 2019 Feb; 19(1):23. PubMed ID: 30770743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycated hemoglobin versus oral glucose tolerance test in the identification of subjects with prediabetes in Qatari population.
    Iskandar S; Migahid A; Kamal D; Megahed O; DeFronzo RA; Zirie M; Jayyousi A; Al Jaidah M; Abdul-Ghani M
    BMC Endocr Disord; 2019 Aug; 19(1):87. PubMed ID: 31438915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of Cardiology.
    Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Sundvall J; Tuomilehto J; Wood D; Rydén L;
    Eur Heart J; 2015 May; 36(19):1171-7. PubMed ID: 25670820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of oral glucose tolerance test and HbA1c in detection of disorders of glucose metabolism in patients with acute stroke.
    Matz K; Tuomilehto J; Teuschl Y; Dachenhausen A; Brainin M
    Cardiovasc Diabetol; 2020 Dec; 19(1):204. PubMed ID: 33278898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validation of two diabetes risk scores in a young UK South Asian population.
    Gray LJ; Khunti K; Wilmot EG; Yates T; Davies MJ
    Diabetes Res Clin Pract; 2014 Jun; 104(3):451-8. PubMed ID: 24785738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening obese children and adolescents for prediabetes and/or type 2 diabetes in pediatric practices: a validation study.
    Brar PC; Mengwall L; Franklin BH; Fierman AH
    Clin Pediatr (Phila); 2014 Jul; 53(8):771-6. PubMed ID: 24671874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting Type 2 diabetes mellitus.
    Mostafa SA; Davies MJ; Webb D; Gray LJ; Srinivasan BT; Jarvis J; Khunti K
    Diabet Med; 2010 Jul; 27(7):762-9. PubMed ID: 20636956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation.
    Ussif AM; Åsberg A; Halden TAS; Nordheim E; Hartmann A; Jenssen T
    BMC Nephrol; 2019 Jan; 20(1):12. PubMed ID: 30630438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of type 2 diabetes mellitus using fasting plasma glucose and HbA1c levels among individuals with impaired fasting plasma glucose: a cross-sectional study in Thailand.
    Sitasuwan T; Lertwattanarak R
    BMJ Open; 2020 Nov; 10(11):e041269. PubMed ID: 33172945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.
    Salinero-Fort MA; Burgos-Lunar C; Lahoz C; Mostaza JM; Abánades-Herranz JC; Laguna-Cuesta F; Estirado-de Cabo E; García-Iglesias F; González-Alegre T; Fernández-Puntero B; Montesano-Sánchez L; Vicent-López D; Cornejo-Del Río V; Fernández-García PJ; Sánchez-Arroyo V; Sabín-Rodríguez C; López-López S; Patrón-Barandio P; Gómez-Campelo P;
    PLoS One; 2016; 11(7):e0158489. PubMed ID: 27441722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not performing an OGTT results in significant underdiagnosis of (pre)diabetes in a high risk adult Caucasian population.
    Meijnikman AS; De Block CEM; Dirinck E; Verrijken A; Mertens I; Corthouts B; Van Gaal LF
    Int J Obes (Lond); 2017 Nov; 41(11):1615-1620. PubMed ID: 28720876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing HbA1c, fasting and 2-h plasma glucose for screening for abnormal glucose regulation in patients undergoing coronary angiography.
    Wang JS; Lee IT; Lee WJ; Lin SY; Fu CP; Lee WL; Liang KW; Sheu WH
    Clin Chem Lab Med; 2015 Aug; 53(9):1441-9. PubMed ID: 25405720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of HbA1c and oral glucose tolerance test for diagnosis of diabetes in patients with coronary artery disease.
    Farhan S; Jarai R; Tentzeris I; Kautzky-Willer A; Samaha E; Smetana P; Jakl-Kotauschek G; Wojta J; Huber K
    Clin Res Cardiol; 2012 Aug; 101(8):625-30. PubMed ID: 22391987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.